GJJ

6-[(3S)-3-(acryloylamino)pyrrolidin-1-yl]-2-{[4-(tert-butylcarbamoyl)phenyl]amino}pyridine-3-carboxamide

Created:	2018-05-23
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where GJJ is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	63
Chiral Atom Count	1
Bond Count	65
Aromatic Bond Count	12

2D diagram of GJJ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	6-[(3S)-3-(acryloylamino)pyrrolidin-1-yl]-2-{[4-(tert-butylcarbamoyl)phenyl]amino}pyridine-3-carboxamide
Systematic Name (OpenEye OEToolkits)	2-[[4-(~{tert}-butylcarbamoyl)phenyl]amino]-6-[(3~{S})-3-(prop-2-enoylamino)pyrrolidin-1-yl]pyridine-3-carboxamide
Formula	C₂₄ H₃₀ N₆ O₃
Molecular Weight	450.533
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c2(Nc1ccc(C(NC(C)(C)C)=O)cc1)c(C(=O)N)ccc(n2)N3CCC(NC(=O)\C=C)C3
SMILES	CACTVS	3.385	CC(C)(C)NC(=O)c1ccc(Nc2nc(ccc2C(N)=O)N3CC[CH](C3)NC(=O)C=C)cc1
SMILES	OpenEye OEToolkits	2.0.6	CC(C)(C)NC(=O)c1ccc(cc1)Nc2c(ccc(n2)N3CCC(C3)NC(=O)C=C)C(=O)N
Canonical SMILES	CACTVS	3.385	CC(C)(C)NC(=O)c1ccc(Nc2nc(ccc2C(N)=O)N3CC[C@@H](C3)NC(=O)C=C)cc1
Canonical SMILES	OpenEye OEToolkits	2.0.6	CC(C)(C)NC(=O)c1ccc(cc1)Nc2c(ccc(n2)N3CC[C@@H](C3)NC(=O)C=C)C(=O)N
InChI	InChI	1.03	InChI=1S/C24H30N6O3/c1-5-20(31)26-17-12-13-30(14-17)19-11-10-18(21(25)32)22(28-19)27-16-8-6-15(7-9-16)23(33)29-24(2,3)4/h5-11,17H,1,12-14H2,2-4H3,(H2,25,32)(H,26,31)(H,27,28)(H,29,33)/t17-/m0/s1
InChIKey	InChI	1.03	AYRMUHGKVWLINC-KRWDZBQOSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL4290066
PubChem	137349435
ChEMBL	CHEMBL4290066

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.